Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan
· Delayed Price · Currency is JPY 3,100.00
-25.00 (-0.80%)
Jun 9, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceutical | 227.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 9.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Cardiovascular System and Respiratory Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Cardiovascular System and Respiratory Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Drugs for Nervous System and Allergies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Drugs for Nervous System and Allergies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Drugs for Gastrointestinal | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Drugs for Gastrointestinal Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Other Metabolic Drug | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Other Metabolic Drug Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Antibiotics and Chemotherapeutic Agents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Antibiotics and Chemotherapeutic Agents Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Vitamins Pills | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Vitamins Pills Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise - Drugs for Nervous System and Allergies | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise - Drugs for Nervous System and Allergies Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finished Goods - Hormone Agent | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Japan | 178.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 14.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 49.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -7.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|